BioNexus Gene Lab Corp Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BioNexus Gene Lab Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q3 2024.
  • BioNexus Gene Lab Corp Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 18M shares, a 0.98% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 18M +175K +0.98% Sep 30, 2024 10-Q 2024-11-15
Q2 2024 17.7M -156M -89.8% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 17.7M -156M -89.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 17.7M +3.19M +22% Dec 31, 2023 10-Q 2024-11-15
Q3 2023 17.8M -156M -89.8% Sep 30, 2023 10-Q/A 2024-03-26
Q2 2023 174M +2.5M +1.46% Jun 30, 2023 10-Q 2023-08-16
Q1 2023 174M +2.5M +1.46% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 14.5M -157M -91.5% Dec 31, 2022 10-K 2024-04-16
Q3 2022 174M +2.5M +1.46% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 171M 0 0% Jun 30, 2022 10-Q 2023-08-16
Q1 2022 171M 0 0% Mar 31, 2022 10-Q 2023-05-09
Q4 2021 171M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 171M +68.5M +66.7% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 171M +68.5M +66.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 171M 0 0% Mar 31, 2021 10-Q 2021-05-18
Q4 2020 171M +68.5M +66.7% Dec 31, 2020 10-K 2022-04-06
Q3 2020 103M +29M +39.4% Sep 30, 2020 10-Q/A 2020-11-09
Q2 2020 103M +28.1M +37.7% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 171M Mar 31, 2020 10-Q 2021-05-18
Q4 2019 103M +28.1M +37.7% Dec 31, 2019 10-K 2021-03-30
Q3 2019 73.7M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 74.6M Jun 30, 2019 10-Q 2019-08-09
Q4 2018 74.6M Dec 31, 2018 10-K 2020-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.